Unravelling the EU’s ERA Guidelines for Medicinal Products: What’s in the Box and What’s Still Missing? Read More
Advancing cosmetic safety: An industry case study using an NGRA framework to support the safety of daidzein in a cosmetic product Read More
The importance of having a solid PC data package to support human health/environmental risk assessment and read across under REACH Read More
Using (Q)SAR and read across to evaluate the toxicological risks of data-poor drug impurities and extractables/leachables Read More
